Drug Trial Radar · NCT07739368
Safety and Efficacy Study of Ferric Maltol To Treat Iron Deficiency Anaemia in Chinese Patients With Inflammatory Bowel Disease
Last checked: Nov 20, 2026Latest source record: Jul 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
122
Actual
Start
Sep 1, 2021
Primary completion
Feb 20, 2025
Study completion Mar 20, 2025
Sponsor
- Lead sponsor
- Jiangsu Aosaikang Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 31, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether Ferric Maltol, an oral ferric iron preparation, is safe and effective in the treatment of iron deficiency anaemia (IDA) in subjects with inflammatory bowel disease (IBD).
Conditions
- Iron Deficiency Anaemia
Interventions
Ferric MaltolDrug
30 mg capsules to be taken orally twice a day for 12 weeks
Placebo Oral CapsuleDrug
Matching placebo capsules for Ferric Maltol to be taken orally twice a day for 12 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Haemoglobin (Hb) Concentration From Baseline to Week 12Time frame: Baseline to Week 12
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Jiangsu Aosaikang Pharm
Nanjing, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.